SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Benny Leonard

PatientBenny Leonard
Date of birth1976-04-07
IdentifiersMRN HR-BX008-SYN; SSN (made up) 000-08-4106
Document date2026-06-30
AuthorMiriam Okafor-Rosenthal, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Seven-week review: home blood pressure, work and symptoms. [S]

History of Present Illness

Mr. Leonard returns seven weeks after intake. His home readings fell below 140/90 mmHg three weeks ago, and Dr. Okafor-Rosenthal cleared him by phone for full cards, as the cardiologist had advised. He has refereed four full cards since, drinking water between bouts, without breathlessness or chest tightness. His home readings over the past two weeks averaged 134/84 mmHg. He takes losartan-hydrochlorothiazide each morning and atorvastatin each evening without muscle aches, cough or lightheadedness. He walks briskly most mornings and eats less salted meat. [S]

ElementDetail
Home blood pressureAverage 134/84 mmHg over two weeks
WorkFour full cards without symptoms
Kidney functionCreatinine 1.06 mg/dL, potassium 3.9 mmol/L

Review of Systems

SystemResultFinding
CardiovascularNegativeNo chest tightness, palpitations, fainting or ankle swelling
RespiratoryNegativeNo breathlessness at work
MusculoskeletalNegativeNo muscle aches on atorvastatin

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Losartan 50 mg with hydrochlorothiazide 12.5 mg, one tablet each morningOne tablet each morningOral route2026-05-12 to 2026-06-30completedS
Losartan 100 mg with hydrochlorothiazide 25 mg, one tablet each morningOne tablet each morning; held from the sick visit; stopped at the preventive visitOral route2026-06-30 to 2026-07-28stoppedS
Atorvastatin 40 mg tablet, one each eveningOne tablet each eveningOral route2026-05-26activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-06-30Body height165cmS
2026-06-30Body weight74kgS
2026-06-30Body mass index (BMI) [Ratio]27.2kg/m2S
2026-06-30Systolic blood pressure136mm[Hg]S
2026-06-30Diastolic blood pressure86mm[Hg]S
2026-06-30Heart rate72/minS
2026-06-30Respiratory rate14/minS
2026-06-30Body temperature36.6CelS
2026-06-30Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-30Sodium [Moles/volume] in Serum or Plasma138mmol/L135-146 mmol/LNormalS
2026-06-30Potassium [Moles/volume] in Serum or Plasma3.9mmol/L3.5-5.3 mmol/LNormalS
2026-06-30Urea nitrogen [Mass/volume] in Serum or Plasma17mg/dL7-25 mg/dLNormalS
2026-06-30Creatinine [Mass/volume] in Serum or Plasma1.06mg/dL0.7-1.3 mg/dLNormalS
2026-06-30Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M84mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-06-30Glucose [Mass/volume] in Serum or Plasma95mg/dL65-99 mg/dLNormalS

Physical Exam

Vital signs recorded on 2026-06-30; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 136/86 mmHg, pulse 72; weight 74.0 kg
CardiovascularRegular rhythm; fourth heart sound; no murmur; no edema

Problems

ProblemClinical statusVerificationCodeProvenance
Breathlessness and tightness across the chest on exertion for about two months, late in long nights of refereeing in hot arenas, easing within a few minutes of rest; never at rest; no fainting, palpitations, orthopnea or ankle swelling; cause under evaluation with a cardiology consultationresolvedconfirmed R06.09S — Synthetic presenting problem anchored to his documented work as a referee; superseded at the consultation when stress testing showed no ischemia and the symptom was attributed to hypertensive heart disease.
Stage 2 hypertension found at a yearly fitness examination for his referee's license (164/100 and 160/98 mmHg), with left ventricular hypertrophy by voltage on the ECG; untreated; home readings to followresolvedconfirmed I10S — Synthetic diagnosis at intake; reclassified as hypertensive heart disease after the echocardiogram at the consultation.
Hypertensive heart disease without heart failure: concentric left ventricular hypertrophy (septum 13 mm, mass index 118 g/m2) with normal ejection fraction, grade 1 diastolic dysfunction, a mildly enlarged left atrium and an exaggerated blood pressure rise on exercise; no features of hypertrophic cardiomyopathyactiveconfirmed I11.9S — Synthetic diagnosis made at the cardiology consultation; not a claim about his real heart.
Coronary atherosclerosis found by coronary calcium scoring (Agatston score 186, about the 80th percentile for his age and sex), without angina and with no inducible ischemia on exercise stress echocardiographyactiveconfirmed I25.10S — Synthetic diagnosis made at the cardiology consultation; not a retrospective diagnosis of the cause of his death, which is disputed.
Hypercholesterolemia: LDL 160 mg/dL, HDL 44 mg/dL, lipoprotein(a) not raised; no diabetesactiveconfirmed E78.00S — Synthetic diagnosis at intake.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationClinic blood pressure, average of two seated readingsEvery visitCompleted today136/86 mmHg
Self-managementHome blood pressure monitoring (validated upper-arm cuff), readings sent weeklyEvery day during titration; then a week before each visitCompleted todayTwo-week average 134/84 mmHg
LaboratoryBasic metabolic panel (sodium, potassium, creatinine, eGFR)Two to four weeks after starting or changing an ARB or diuretic; then every six monthsCompleted todaySodium 138, potassium 3.9 mmol/L, creatinine 1.06 mg/dL, eGFR 84; repeat two weeks after today's increase
LaboratoryLipid panelFour to twelve weeks after starting a statin; then yearlyDueAt about nine weeks on atorvastatin
ExaminationSymptoms: exertional chest discomfort, breathlessness, palpitations, faintingEvery visitCompleted todayNone at four full cards
ImagingStress testing or coronary imagingFor new or changed exertional symptoms; not for routine surveillanceNot indicatedNo new symptoms
ImagingEchocardiogramAt diagnosis of stage 2 hypertension or suspected hypertrophy; repeat in six to twelve months to judge regressionUp to dateRepeat six to twelve months after the first
ExaminationWeight, BMI and physical activityEvery visitCompleted today74.0 kg; brisk walks most mornings
Medication safetyAdherence and side effects (cough, edema, muscle aches, lightheadedness)Every visitCompleted todayNo missed doses; no cough, lightheadedness or muscle aches
Self-managementReturn to work: refereeing, heat and hydration, warning symptoms, defibrillator at the venueBefore return to full exertion; then every visitCompleted todayCleared for full cards three weeks ago; water between bouts
Self-managementFinancial strain and medicine costEvery visitCompleted todayBoth medicines are generics he can afford

Goal progress:

Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia (2026); Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension (2015); CMID: Clinical Monitoring Intelligence Database, hypertension, hyperlipidemia and ischemic heart disease monographs (2026)

Follow-up: Basic metabolic panel in two weeks. Preventive visit at the end of July with the lipid panel. Fifteen-week review in late August. Next scheduled visit 2026-07-28: periodic adult preventive visit and recheck after the sick visit. [S]